Tenet, Acadia and Community Health Systems have been highlighted in this Industry Outlook article.
Acadia Healthcare's revenue growth has stalled at -0.4% YoY in Q2 2026, with gross margins compressing to 16.6% from 96.7% a year earlier, reflecting cost reclassification and labor inflation. The company faces significant legal and litigation risks, evidenced...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 28, 2026 | $0.38+9.7% vs $0.35 | $866M+2.6% vs $844M |
Q2 2026 Apr 29, 2026 | $0.37+32.1% vs $0.28 | $829M+0.6% vs $824M |
Q1 2026 Feb 25, 2026 | $0.07+133.3% vs $0.03 | $821M+2.7% vs $800M |
Q4 2025 Nov 5, 2025 | $0.72+5.9% vs $0.68 | $852M+0.4% vs $848M |
Tenet, Acadia and Community Health Systems have been highlighted in this Industry Outlook article.
The Zacks Medical-Hospital operators are benefiting from steady care demand while sharpening efficiency and portfolio strategy. Investors may want to track THC, ACHC and CYH.
Short sellers are making bold bets, and the numbers behind those bets are getting harder to ignore. Pessimism this concentrated can set the stage for sharp reversals, since a heavily shorted stock only needs a piece of good news to send bears scrambling to cover their positions.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the 2026 Jefferies Healthcare Services and Technology Conference on September 14th. In connection with the conference, there will be an online webcast of the Company's presentation starting at 2:25 p.m. Central Time / 3:25 p.m. Eastern Time on September 14, 2026. The live webcast of the presentation will be available on the Company's website, w.
Benchmark ACHC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Acadia Healthcare Company, Inc. (ACHC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $28.51 | $2.65B | -2.34 | 5.04% | -33.29% | -41.37% | — | |
| $181.39 | $10.98B | 7.85 | 9.71% | 8.42% | 20.37% | — | |
| $16.51 | $2.05B | 13.99 | 5.12% | 2.42% | 6.55% | — | |
| $14.56 | $1.9B | -23.87 | 6.24% | -2.63% | -2.59% | — | |
| $11.17 | $2.67B | -10.06 | 4.77% | -4.59% | — | — | |
| $175.46 | $10.23B | 30.04 | 18.72% | 6.9% | 16.51% | — |
Acadia Healthcare Company, Inc. (ACHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Acadia Healthcare Company, Inc. (ACHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 28, 2026·SEC
May 18, 2026·SEC
May 6, 2026·SEC
Get notified when ACHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Acadia Healthcare Company, Inc. (ACHC) stock FAQ — growth, dividends, profitability & financials explained
Acadia Healthcare Company, Inc. (ACHC) reported $3.37B in revenue for fiscal year 2025. This represents a 1421% increase from $221.4M in 2011.
Acadia Healthcare Company, Inc. (ACHC) grew revenue by 5.0% over the past year. This is steady growth.
Acadia Healthcare Company, Inc. (ACHC) reported a net loss of $1.13B for fiscal year 2025.
Acadia Healthcare Company, Inc. (ACHC) has a return on equity (ROE) of -41.4%. Negative ROE indicates the company is unprofitable.
Acadia Healthcare Company, Inc. (ACHC) had negative free cash flow of $18.9M in fiscal year 2025, likely due to heavy capital investments.